Loading video...

Video Failed to Load

Go Home

NAD+ has been studied since 1906. It has 2 Nobel Prizes, randomized human trials, and over a century of biochemistry behind it. Yet in 2017, the FDA advisory committee voted against adding it to the 503A bulks list. The reason wasn't what most people think.

45,084 views • 1 month ago •via X (Twitter)

0 Comments

No comments available

Comments from the original post will appear here

Related Videos